SERAX Side Effects

6335125-7 | Heart Rate Increased, Impaired Work Ability, Pyrexia
on Aug 28, 2009 Male patient from UNITED STATES , 40 years of age, weighting 200.0 lb, was treated with Serax (View Usage). Patient experienced the following unwanted or unexpected effects: heart rate increased, impaired work ability, pyrexia. Serax dosage: 1981 Or 2.

6248561-4 | Agitation, Unevaluable Event
Patient was taking Serax (View Usage). Patient had the following side effects: agitation, unevaluable event on Jun 24, 2009 from UNITED STATES Additional patient health information: Female patient , 48 years of age, was diagnosed with prophylaxis and. Serax dosage: 15mg Po Q8hr.

4911183-9 | Arteriosclerosis Coronary Artery, Coronary Artery Stenosis, Myocardial Infarction
Adverse event was reported on Jan 31, 2006 by a Male patient taking Serax (View Usage) (Dosage: Po) was diagnosed with anxiety (What is anxiety?), depression (What is depression?), osteoarthritis (What is osteoarthritis?), back pain (What is back pain?), lipid metabolism disorder and. Location: FRANCE , 55 years of age, After Serax was administered, patient had the following side effects: arteriosclerosis coronary artery, coronary artery stenosis, myocardial infarction. During the same period patient was treated with ATHYMIL ({NULL}) (Po) (View Athymil ({null}) Review and Athymil ({null}) Label ), CELEBREX (View Celebrex Review and Celebrex Label ), PROPOFAN ({NULL}) (Po) (View Propofan ({null}) Review and Propofan ({null}) Label ), VASTEN ({NULL}) (Po) (View Vasten ({null}) Review and Vasten ({null}) Label ), ACEBUTOLOL (View Acebutolol Review and Acebutolol Label ), TRIATEC (View Triatec Review and Triatec Label ), TEMESTA (View Temesta Review and Temesta Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

4875704-7 | Intentional Overdose
on Dec 28, 2005 Male patient from FRANCE , 39 years of age, was treated with Serax (View Usage). Patient experienced the following unwanted or unexpected effects: intentional overdose. Serax dosage: 200 Mg;qd;po. During the same period patient was treated with TERCIAN (View Tercian Review and Tercian Label ), METHADONE (View Methadone Review and Methadone Label ). Patient was hospitalized.


4872190-8 | Confusional State, Disorientation
on Dec 21, 2005 Female patient from FRANCE , 79 years of age, was diagnosed with depression (What is depression?) and was treated with Serax (View Usage). Patient had the following side effects: confusional state, disorientation. Serax dosage: Po. During the same period patient was treated with DI ANTALVIC (View Di-antalvic Review and Di-antalvic Label ). Patient was hospitalized.

4860911-X | Back Pain, Fall
Patient was taking Serax (View Usage). After Serax was administered, patient had the following side effects: back pain (What is back pain?), fall (What is fall?) on Dec 06, 2005 from UNITED STATES Additional patient health information: Female patient , 80 years of age, . Serax dosage: 10mg;qd; Po. During the same period patient was treated with BROMAZEPAM ({NULL}) (3 Mg;qd; Po) (View Bromazepam ({null}) Review and Bromazepam ({null}) Label ), DI ANTALVIC ({NULL}) (6 Unk; Qd; Po) (View Di-antalvic ({null}) Review and Di-antalvic ({null}) Label ), TOPALGIC ({NULL}) (300 Mg;qd; Po) (View Topalgic ({null}) Review and Topalgic ({null}) Label ). Patient was hospitalized.

4828565-6 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased, Hypercholesterolaemia, Hypertriglyceridaemia
Adverse event was reported on Oct 31, 2005 by a Female patient taking Serax (View Usage) (Dosage: See Image) . Location: AUSTRIA , 53 years of age, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, hypercholesterolaemia, hypertriglyceridaemia. During the same period patient was treated with LEPONEX ^NOVARTIS^ ({NULL}) (75 Mg; Qd; Po) (View Leponex ^novartis^ ({null}) Review and Leponex ^novartis^ ({null}) Label ), VENLAFAXINE HYDROCHLORIDE (300 Mg; Qd) (View Venlafaxine Hydrochloride Review and Venlafaxine Hydrochloride Label ). Patient was hospitalized.

4828564-4 | Constipation, Urinary Retention
on Nov 01, 2005 Female patient from SWEDEN , 52 years of age, was treated with Serax (View Usage). Patient had the following side effects: constipation (What is constipation?), urinary retention. Serax dosage: See Image. During the same period patient was treated with MIRTAZAPINE ({NULL}) (See Image) (View Mirtazapine ({null}) Review and Mirtazapine ({null}) Label ), VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ). Patient was hospitalized.

4827628-9 | Cerebral Disorder, Encephalitis, Neuroleptic Malignant Syndrome
on Nov 07, 2005 Female patient from FRANCE , 68 years of age, was treated with Serax (View Usage). After Serax was administered, patient had the following side effects: cerebral disorder, encephalitis (What is encephalitis?), neuroleptic malignant syndrome. Serax dosage: . During the same period patient was treated with IXPRIM (Po) (View Ixprim Review and Ixprim Label ), LAROXYL (Po) (View Laroxyl Review and Laroxyl Label ), NEURONTIN (Po) (View Neurontin Review and Neurontin Label ). Patient was hospitalized.

4819010-5 | Blood Pressure Decreased, Coma, Glasgow Coma Scale Abnormal, Heart Rate Increased, Oxygen Saturation Decreased, Suicide Attempt
Patient was taking Serax (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, coma, glasgow coma scale abnormal, heart rate increased, oxygen saturation decreased, suicide attempt on Oct 25, 2005 from FRANCE Additional patient health information: Female patient , 57 years of age, . Serax dosage: See Image. During the same period patient was treated with MEPRONIZINE ({NULL}) (See Image) (View Mepronizine ({null}) Review and Mepronizine ({null}) Label ). Patient was hospitalized.

4811533-8 | Blood Alcohol Increased, Overdose
Adverse event was reported on Oct 14, 2005 by a Female patient taking Serax (View Usage) (Dosage: Po) . Location: FRANCE , 40 years of age, Patient had the following side effects: blood alcohol increased, overdose. During the same period patient was treated with ALCOHOL (View Alcohol Review and Alcohol Label ), LOXAPAC (View Loxapac Review and Loxapac Label ).

4805499-4 | Convulsion, Hyperthyroidism
on Oct 06, 2005 Female patient from UNITED STATES , 61 years of age, was diagnosed with anxiety (What is anxiety?), bipolar i disorder, hypothyroidism and was treated with Serax (View Usage). After Serax was administered, patient had the following side effects: convulsion, hyperthyroidism. Serax dosage: 50 Mg; Qd; Po. During the same period patient was treated with EFFEXOR XR (75 Mg;qd; Po; 37.5 Mg; Qd; Po) (View Effexor Xr Review and Effexor Xr Label ), DEPAMIDE (Po) (View Depamide Review and Depamide Label ), LAROXYL (25 Mg; Qd; Po) (View Laroxyl Review and Laroxyl Label ), LEVOTHYROX (100 Ug; Qd; Po; 75 Ug; Qd; Po) (View Levothyrox Review and Levothyrox Label ), TERCIAN (15 Mg; Qd; Po) (View Tercian Review and Tercian Label ), TAMOXIFEN (View Tamoxifen Review and Tamoxifen Label ). Patient was hospitalized.

4787085-8 | Aseptic Necrosis Bone, Metastases To Bone, Mucosal Ulceration
on Sep 20, 2005 Male patient from FRANCE , 46 years of age, was diagnosed with metastases to bone and was treated with Serax (View Usage). Patient experienced the following unwanted or unexpected effects: aseptic necrosis bone, metastases to bone, mucosal ulceration. Serax dosage: Po. During the same period patient was treated with BI PROFENID ({NULL}) (Po) (View Bi-profenid ({null}) Review and Bi-profenid ({null}) Label ), DUROGESIC ({NULL}) (Tder) (View Durogesic ({null}) Review and Durogesic ({null}) Label ), HYCAMTIN (Iv) (View Hycamtin Review and Hycamtin Label ), ZOMETA (4 Mg; Q3w; Iv) (View Zometa Review and Zometa Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), SKENAN (View Skenan Review and Skenan Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ). Patient was hospitalized.

4786081-4 | Coma, Condition Aggravated, Fall, Intracranial Injury, Loss Of Consciousness, Renal Failure, Restlessness
Patient was taking Serax (View Usage). Patient had the following side effects: coma, condition aggravated, fall (What is fall?), intracranial injury, loss of consciousness, renal failure, restlessness on Sep 20, 2005 from FRANCE Additional patient health information: Male patient , 63 years of age, . Serax dosage: Po. During the same period patient was treated with LARGACTIL {NULL} (Po) (View Largactil {null} Review and Largactil {null} Label ), NOCTRAN 10 {NULL} (Iv) (View Noctran 10 {null} Review and Noctran 10 {null} Label ), NOZINAN /00038602/ ({NULL}) (Po) (View Nozinan /00038602/ ({null}) Review and Nozinan /00038602/ ({null}) Label ), TRANXENE ({NULL}) (50- Mg;qd;po) (View Tranxene ({null}) Review and Tranxene ({null}) Label ). Patient was hospitalized.

4773095-3 | Catatonia, Cogwheel Rigidity, Dysstasia, Extrapyramidal Disorder, Fall, Muscle Hypertrophy, Muscle Spasticity, Nervous System Disorder, Psychomotor Retardation
Adverse event was reported on Sep 12, 2005 by a Female patient taking Serax (View Usage) (Dosage: Po) . Location: UNITED STATES , 56 years of age, After Serax was administered, patient had the following side effects: catatonia, cogwheel rigidity, dysstasia, extrapyramidal disorder, fall (What is fall?), muscle hypertrophy, muscle spasticity, nervous system disorder, psychomotor retardation. During the same period patient was treated with LAMALINE /OLD FORM/ (Po) (View Lamaline /old Form/ Review and Lamaline /old Form/ Label ), NOCERTONE (View Nocertone Review and Nocertone Label ), PROZAC (Po) (View Prozac Review and Prozac Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), FORLAX (View Forlax Review and Forlax Label ). Patient was hospitalized.

4773064-3 | Bronchitis, Diabetes Mellitus Non-insulin-dependent, Diabetic Hyperosmolar Coma
on Sep 06, 2005 Male patient from UNITED STATES , 79 years of age, was treated with Serax (View Usage). Patient experienced the following unwanted or unexpected effects: bronchitis (What is bronchitis?), diabetes mellitus non-insulin-dependent, diabetic hyperosmolar coma. Serax dosage: 30 Mg; Qd; Po. During the same period patient was treated with KADIAN (Qd; Po) (View Kadian Review and Kadian Label ), TETRAZEPAM ({NULL}) (Qd;po) (View Tetrazepam ({null}) Review and Tetrazepam ({null}) Label ), RISPERDAL (Qd;po) (View Risperdal Review and Risperdal Label ), CITALOPRAM HYDROCHLORIDE ({NULL}) (0.5 Ml;qd) (View Citalopram Hydrochloride ({null}) Review and Citalopram Hydrochloride ({null}) Label ). Patient was hospitalized.

4767640-1 | Atrioventricular Block, Bundle Branch Block Right, Chest Pain, Extrasystoles, Hypotension, Leukocyturia, Loss Of Consciousness, Malaise
on Sep 01, 2005 Female patient from UNITED STATES , 93 years of age, was treated with Serax (View Usage). Patient had the following side effects: atrioventricular block, bundle branch block right, chest pain (What is chest pain?), extrasystoles, hypotension, leukocyturia, loss of consciousness, malaise. Serax dosage: 10 Mg;qd; Po. During the same period patient was treated with EXELON ({NULL}) (3 Mg;qd; Po) (View Exelon ({null}) Review and Exelon ({null}) Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), CALCEOS (View Calceos Review and Calceos Label ). Patient was hospitalized.

4765795-6 | Grand Mal Convulsion
Patient was taking Serax (View Usage). After Serax was administered, patient had the following side effects: grand mal convulsion on Aug 31, 2005 from UNITED STATES Additional patient health information: Male patient , 45 years of age, was diagnosed with anxiety (What is anxiety?), epilepsy (What is epilepsy?) and. Serax dosage: Qd; Po. During the same period patient was treated with BUSPAR (30 Mg; Qd; Po) (View Buspar Review and Buspar Label ), EQUANIL (Qd; Po) (View Equanil Review and Equanil Label ), PHENOBARBITAL TAB (Qd; Po) (View Phenobarbital Tab Review and Phenobarbital Tab Label ), TEGRETOL (Qd; Po) (View Tegretol Review and Tegretol Label ), TIAPRIDAL (Qd; Po) (View Tiapridal Review and Tiapridal Label ), PARKINANE (View Parkinane Review and Parkinane Label ). Patient was hospitalized.

4765675-6 | Atrioventricular Block, Bundle Branch Block, Chest Pain, Hypotension, Leukocyturia, Malaise, Neutrophil Count Increased, Nitrite Urine Present
Adverse event was reported on Jun 23, 2005 by a Female patient taking Serax (View Usage) (Dosage: 10 Mg, Qd; Po) . Location: UNITED STATES , 93 years of age, Patient experienced the following unwanted or unexpected effects: atrioventricular block, bundle branch block, chest pain (What is chest pain?), hypotension, leukocyturia, malaise, neutrophil count increased, nitrite urine present. During the same period patient was treated with EXELON (View Exelon Review and Exelon Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), CALCEOS (View Calceos Review and Calceos Label ). Patient was hospitalized.

4765529-5 | Flushing, Hot Flush
on Aug 29, 2005 Female patient from UNITED STATES , 51 years of age, was treated with Serax (View Usage). Patient had the following side effects: flushing, hot flush. Serax dosage: Qd Po. During the same period patient was treated with MOGADON ({NULL}) (Qd Po) (View Mogadon ({null}) Review and Mogadon ({null}) Label ), EQUANIL (Po) (View Equanil Review and Equanil Label ). Patient was hospitalized.

4759251-9 | Catatonia, Cogwheel Rigidity, Extrapyramidal Disorder, Fall, Hypertrophy, Nervous System Disorder, Psychomotor Retardation, Venous Angioma Of Brain
on Aug 25, 2005 Female patient from UNITED STATES , 56 years of age, was treated with Serax (View Usage). After Serax was administered, patient had the following side effects: catatonia, cogwheel rigidity, extrapyramidal disorder, fall (What is fall?), hypertrophy, nervous system disorder, psychomotor retardation, venous angioma of brain. Serax dosage: Po. During the same period patient was treated with LAMALINE /OLD FORM/ ({NULL}) (Po) (View Lamaline /old Form/ ({null}) Review and Lamaline /old Form/ ({null}) Label ), NOCERTONE ({NULL}) (View Nocertone ({null}) Review and Nocertone ({null}) Label ), PROZAC (Po) (View Prozac Review and Prozac Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), FORLAX (View Forlax Review and Forlax Label ). Patient was hospitalized.

4753696-9 | Catatonia, Cogwheel Rigidity, Extrapyramidal Disorder, Fall, Flat Affect, Hypertrophy, Muscle Spasticity, Psychomotor Skills Impaired, Venous Angioma Of Brain
Patient was taking Serax (View Usage). Patient experienced the following unwanted or unexpected effects: catatonia, cogwheel rigidity, extrapyramidal disorder, fall (What is fall?), flat affect, hypertrophy, muscle spasticity, psychomotor skills impaired, venous angioma of brain on Aug 11, 2005 from FRANCE Additional patient health information: Female patient , 56 years of age, . Serax dosage: Po. During the same period patient was treated with LAMALINE/OLD FORM/ ({NULL}) (Po) (View Lamaline/old Form/ ({null}) Review and Lamaline/old Form/ ({null}) Label ), NOCERTONE ({NULL}) (View Nocertone ({null}) Review and Nocertone ({null}) Label ), PROZAC (Po) (View Prozac Review and Prozac Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), FORLAX (View Forlax Review and Forlax Label ). Patient was hospitalized.

4733194-9 | Grand Mal Convulsion
Adverse event was reported on Jul 20, 2005 by a Male patient taking Serax (View Usage) (Dosage: Qd; Po) was diagnosed with anxiety (What is anxiety?), epilepsy (What is epilepsy?) and. Location: FRANCE , 45 years of age, Patient had the following side effects: grand mal convulsion. During the same period patient was treated with BUSPAR (30 Mg;qd; Po) (View Buspar Review and Buspar Label ), EQUANIL (Qd; Po) (View Equanil Review and Equanil Label ), PHENOBARBITAL ({NULL}) (Qd; Po) (View Phenobarbital ({null}) Review and Phenobarbital ({null}) Label ), TEGRETOL (Qd; Po) (View Tegretol Review and Tegretol Label ), TIAPRIDAL ({NULL}) (Qd; Po) (View Tiapridal ({null}) Review and Tiapridal ({null}) Label ), PARKINANE (View Parkinane Review and Parkinane Label ). Patient was hospitalized.

4733188-3 | Rash Papular, Rash Pruritic
on Jul 21, 2005 Male patient from FRANCE , 46 years of age, was diagnosed with persecutory delusion and was treated with Serax (View Usage). After Serax was administered, patient had the following side effects: rash papular, rash pruritic. Serax dosage: 150 Mg; Qd; Po. During the same period patient was treated with ABILIFY (15 Mg ;qd; Po) (View Abilify Review and Abilify Label ), NOCTRAN 10 ({NULL}) (Qd; Po) (View Noctran 10 ({null}) Review and Noctran 10 ({null}) Label ). Patient was hospitalized.

4720852-5 | Face Oedema, Gamma-glutamyltransferase Increased, Inflammation, Leukocytosis, Neutrophil Count Increased, Rash Papular, Urticaria
on Jul 07, 2005 Female patient from UNITED STATES , 40 years of age, was diagnosed with anxiety (What is anxiety?), depression (What is depression?) and was treated with Serax (View Usage). Patient experienced the following unwanted or unexpected effects: face oedema, gamma-glutamyltransferase increased, inflammation, leukocytosis, neutrophil count increased, rash papular, urticaria. Serax dosage: Po. During the same period patient was treated with PROZAC (Po) (View Prozac Review and Prozac Label ), TERCIAN (Po) (View Tercian Review and Tercian Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), DAONIL (View Daonil Review and Daonil Label ), ELISOR (View Elisor Review and Elisor Label ). Patient was hospitalized.

4709198-9 | Atrioventricular Block, Bundle Branch Block Right, Chest Pain, Extrasystoles, Hypotension, Leukocytosis, Leukocyturia, Malaise, Nitrite Urine Present
Patient was taking Serax (View Usage). Patient had the following side effects: atrioventricular block, bundle branch block right, chest pain (What is chest pain?), extrasystoles, hypotension, leukocytosis, leukocyturia, malaise, nitrite urine present on Jun 23, 2005 from FRANCE Additional patient health information: Female patient , 93 years of age, . Serax dosage: 10 Mg; Qd; Po. During the same period patient was treated with EXELON (3 Mg Qd; Po) (View Exelon Review and Exelon Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ), LEVOTHYROX (View Levothyrox Review and Levothyrox Label ), CALCEOS (View Calceos Review and Calceos Label ). Patient was hospitalized.

4708868-6 | Depressed Level Of Consciousness, Somnolence, Therapeutic Response Increased
Adverse event was reported on Jun 20, 2005 by a Male patient taking Serax (View Usage) (Dosage: 10 Mg, Qd; Po) was diagnosed with sleep disorder (What is sleep disorder?) and. Location: FRANCE , 70 years of age, After Serax was administered, patient had the following side effects: depressed level of consciousness, somnolence, therapeutic response increased. During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ), EQUANIL (View Equanil Review and Equanil Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), ISOPHANE INSULIN (View Isophane Insulin Review and Isophane Insulin Label ). Patient was hospitalized.

4708866-2 | Intentional Misuse, Overdose, Pneumonia Aspiration, Rhabdomyolysis, Suicide Attempt
on Jun 20, 2005 Male patient from FRANCE , 47 years of age, was treated with Serax (View Usage). Patient experienced the following unwanted or unexpected effects: intentional misuse, overdose, pneumonia aspiration, rhabdomyolysis, suicide attempt. Serax dosage: Po. During the same period patient was treated with ALCOHOL ( {NULL}) (Oral) (View Alcohol ( {null}) Review and Alcohol ( {null}) Label ), MEPRONIZINE ({NULL}) (Po) (View Mepronizine ({null}) Review and Mepronizine ({null}) Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), PROZAC (View Prozac Review and Prozac Label ), PERINDOPRIL (View Perindopril Review and Perindopril Label ), ESOMPRAZOLE (View Esomprazole Review and Esomprazole Label ). Patient was hospitalized.

4705659-7 | Anorexia, Cachexia, Cytolytic Hepatitis
on Jun 17, 2005 Female patient from , 67 years of age, was treated with Serax (View Usage). Patient had the following side effects: anorexia, cachexia, cytolytic hepatitis. Serax dosage: Po. During the same period patient was treated with PIROXICAM (20 Mg;qd;po) (View Piroxicam Review and Piroxicam Label ), HEXAQUINE (Po) (View Hexaquine Review and Hexaquine Label ), ENALAPRIL MALEATE (20 Mg; Qd; Po) (View Enalapril Maleate Review and Enalapril Maleate Label ), ZOLOFT (50 Mg; Qd; Po) (View Zoloft Review and Zoloft Label ), EFFERALGAN (INFANTS' APAP DROPS (ACETAMINOPHEN) (ALPHARMA) (3 Gm; Qd; Po) (View Efferalgan (infants' Apap Drops (acetaminophen) (alpharma) Review and Efferalgan (infants' Apap Drops (acetaminophen) (alpharma) Label ), DAFLON (View Daflon Review and Daflon Label ), LEVOTHYROX (View Levothyrox Review and Levothyrox Label ), CARTEOL (View Carteol Review and Carteol Label ). Patient was hospitalized.

4698004-7 | Face Oedema, Gamma-glutamyltransferase Increased, Inflammation, Leukocytosis, Neutrophil Count Increased, Rash Papular, Urticaria
Patient was taking Serax (View Usage). After Serax was administered, patient had the following side effects: face oedema, gamma-glutamyltransferase increased, inflammation, leukocytosis, neutrophil count increased, rash papular, urticaria on Jun 09, 2005 from Additional patient health information: Female patient , 40 years of age, was diagnosed with anxiety (What is anxiety?), depression (What is depression?) and. Serax dosage: Po. During the same period patient was treated with PROZAC (Po) (View Prozac Review and Prozac Label ), TERCIAN ({NULL}) (Po) (View Tercian ({null}) Review and Tercian ({null}) Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), DAONIL (View Daonil Review and Daonil Label ), ELISOR (View Elisor Review and Elisor Label ). Patient was hospitalized.

4697871-0 | Accidental Overdose, Balance Disorder
Adverse event was reported on Jun 14, 2005 by a Male patient taking Serax (View Usage) (Dosage: Po) . Location: , child 3 years of age, Patient experienced the following unwanted or unexpected effects: accidental overdose, balance disorder.

4697854-0 | Eosinophilia, Urticaria
on Jun 15, 2005 Female patient from , 76 years of age, was treated with Serax (View Usage). Patient had the following side effects: eosinophilia, urticaria. Serax dosage: 25 Mg Qd Po. During the same period patient was treated with EQUANIL (750 Mg; Qd; Po) (View Equanil Review and Equanil Label ), PREVISCAN ({NULL}) (20 Mg; Qd; Po) (View Previscan ({null}) Review and Previscan ({null}) Label ), COVERSYL (View Coversyl Review and Coversyl Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), DETENSIEL (View Detensiel Review and Detensiel Label ). Patient was hospitalized.

4692230-9 | Completed Suicide
on Jun 07, 2005 Male patient from , 32 years of age, was treated with Serax (View Usage). After Serax was administered, patient had the following side effects: completed suicide. Serax dosage: 110 Mg;qd;po. During the same period patient was treated with BEZALIP ({NULL}) (400 Mg;qd;po) (View Bezalip ({null}) Review and Bezalip ({null}) Label ), GLADEM ({NULL}) (150mg;qd;po) (View Gladem ({null}) Review and Gladem ({null}) Label ), IVADAL ({NULL}) (10 Mg;qd;po) (View Ivadal ({null}) Review and Ivadal ({null}) Label ), SOLIAN ({NULL}) (800 Mg;qd;po) (View Solian ({null}) Review and Solian ({null}) Label ).

4691124-2 | Hepatocellular Damage, Liver Disorder, Somnolence
Patient was taking Serax (View Usage). Patient experienced the following unwanted or unexpected effects: hepatocellular damage, liver disorder, somnolence on Jun 01, 2005 from Additional patient health information: Female patient , 73 years of age, . Serax dosage: 50 Mg. During the same period patient was treated with DALFAGAN (PARACETAMOL) ({NULL}) (500 Mg; Prn; Po) (View Dalfagan (paracetamol) ({null}) Review and Dalfagan (paracetamol) ({null}) Label ), IMOVANE (7.5 Mg; Po) (View Imovane Review and Imovane Label ), PLAVIX (View Plavix Review and Plavix Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), EUTHYROX (View Euthyrox Review and Euthyrox Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), SODIUM BICARBONATE (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ). Patient was hospitalized.

4673342-2 | Pneumonia Aspiration, Somnolence, Vomiting
Adverse event was reported on May 13, 2005 by a Male patient taking Serax (View Usage) (Dosage: 50 Mg; Tid; Po) was diagnosed with asthma (What is asthma?) and. Location: , 28 years of age, Patient had the following side effects: pneumonia aspiration, somnolence, vomiting. During the same period patient was treated with ARTANE (View Artane Review and Artane Label ), LYSANXIA (View Lysanxia Review and Lysanxia Label ), RIVOTRIL (3 Mg; Qid; Po) (View Rivotril Review and Rivotril Label ), SUBUTEX (6 Mg; Qd; Po) (View Subutex Review and Subutex Label ), TERCIAN (100 Mg; Qid; Po) (View Tercian Review and Tercian Label ), VENTOLIN (Prn) (View Ventolin Review and Ventolin Label ). Patient was hospitalized.

4659576-1 | Feeding Problem In Newborn, Hypotonia Neonatal, Jaundice Neonatal, Overdose, Poor Weight Gain Neonatal, Suicide Attempt, Tremor Neonatal
on Apr 27, 2005 Male patient from , child 0 years of age, was treated with Serax (View Usage). After Serax was administered, patient had the following side effects: feeding problem in newborn, hypotonia neonatal, jaundice neonatal, overdose, poor weight gain neonatal, suicide attempt, tremor neonatal. Serax dosage: 80 Mg; Qd; Po : X1; Po. During the same period patient was treated with ALCOHOL (X1) (View Alcohol Review and Alcohol Label ), ANAFRANIL (150 Mg; X1;po : 750 Mg;x1;po) (View Anafranil Review and Anafranil Label ), ETOMIDATE (View Etomidate Review and Etomidate Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), LARGACTIL (1250 Mg; X1;po) (View Largactil Review and Largactil Label ), NORSET (300 Mg;x1; Po) (View Norset Review and Norset Label ). Patient was hospitalized.

4659385-3 | Blood Amylase Increased, Oesophageal Ulcer Haemorrhage
on May 02, 2005 Female patient from , 78 years of age, was treated with Serax (View Usage). Patient experienced the following unwanted or unexpected effects: blood amylase increased, oesophageal ulcer haemorrhage. Serax dosage: Po. During the same period patient was treated with GAVISCON (Po) (View Gaviscon Review and Gaviscon Label ), MOPRAL (Po) (View Mopral Review and Mopral Label ), DOMPERIDONE (Po) (View Domperidone Review and Domperidone Label ), PIROXICAM (Qd; Po) (View Piroxicam Review and Piroxicam Label ), TETRAZEPAM (Po) (View Tetrazepam Review and Tetrazepam Label ). Patient was hospitalized.

4659384-1 | Accidental Overdose, Blood Pressure Increased, Fall, Heart Rate Increased
Patient was taking Serax (View Usage). Patient had the following side effects: accidental overdose, blood pressure increased, fall (What is fall?), heart rate increased on May 03, 2005 from Additional patient health information: Female patient , 92 years of age, was diagnosed with psychomotor agitation, sedation and. Serax dosage: Po. During the same period patient was treated with HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), LEXOTANIL (View Lexotanil Review and Lexotanil Label ). Patient was hospitalized.

4659383-X | Pneumonia Aspiration, Somnolence, Vomiting
Adverse event was reported on May 03, 2005 by a Male patient taking Serax (View Usage) (Dosage: 50 Mg; Tid; Po) . Location: , 28 years of age, After Serax was administered, patient had the following side effects: pneumonia aspiration, somnolence, vomiting. During the same period patient was treated with ARTANE (View Artane Review and Artane Label ), LYSANXIA (View Lysanxia Review and Lysanxia Label ), RIVOTRIL (3 Mg; Qid; Po) (View Rivotril Review and Rivotril Label ), SUBUTEX (6 Mg; Qd; Po) (View Subutex Review and Subutex Label ), TERCIAN (100 Mg; Qid; Po) (View Tercian Review and Tercian Label ), VENTOLIN (View Ventolin Review and Ventolin Label ). Patient was hospitalized.

4659359-2 | Blood Alcohol Increased, Blood Glucose Decreased, Coma, Hypotension, Intentional Misuse, Oxygen Saturation Decreased, Suicide Attempt
on Apr 27, 2005 Female patient from , 32 years of age, was treated with Serax (View Usage). Patient experienced the following unwanted or unexpected effects: blood alcohol increased, blood glucose decreased, coma, hypotension, intentional misuse, oxygen saturation decreased, suicide attempt. Serax dosage: See Image, Po. During the same period patient was treated with ALCOHOL (X1) (View Alcohol Review and Alcohol Label ), ANAFRANIL (See Image) (View Anafranil Review and Anafranil Label ), LARGACTIL (1250 Mg; Xl; Po) (View Largactil Review and Largactil Label ), NORSET (300 Mg Xl Po) (View Norset Review and Norset Label ). Patient was hospitalized.

4659358-0 | Anxiety, Hot Flush, Tremor
on Apr 27, 2005 Female patient from , 51 years of age, was treated with Serax (View Usage). Patient had the following side effects: anxiety (What is anxiety?), hot flush, tremor. Serax dosage: 50 M; Bid; Po. During the same period patient was treated with DEPAKOTE (1500 Mg; Qd; Po) (View Depakote Review and Depakote Label ), EQUANIL (400 Mg; Qd; Po) (View Equanil Review and Equanil Label ), MOGADON (2.5 Mg; Qd; Po) (View Mogadon Review and Mogadon Label ), SOLIAN (300 Mg; Qd) (View Solian Review and Solian Label ). Patient was hospitalized.

4647165-4 | Haemodynamic Instability, Hepatic Failure, Influenza Like Illness, Pancytopenia, Pneumococcal Infection, Respiratory Failure, Septic Shock
Patient was taking Serax (View Usage). After Serax was administered, patient had the following side effects: haemodynamic instability, hepatic failure, influenza like illness, pancytopenia, pneumococcal infection, respiratory failure, septic shock on Apr 13, 2005 from Additional patient health information: Male patient , 44 years of age, was diagnosed with chronic hepatitis and. Serax dosage: Po. During the same period patient was treated with ROFERON A (135 Ug; Qw; Po) (View Roferon-a Review and Roferon-a Label ), RIBAVIRIN (Po) (View Ribavirin Review and Ribavirin Label ), TERCIAN (Po) (View Tercian Review and Tercian Label ). Patient was hospitalized.

4639107-2 | Acute Respiratory Distress Syndrome, Alcoholism, Coma, Fall
Adverse event was reported on Apr 12, 2005 by a Male patient taking Serax (View Usage) (Dosage: ) was diagnosed with alcohol withdrawal syndrome and. Location: , 57 years of age, Patient experienced the following unwanted or unexpected effects: acute respiratory distress syndrome, alcoholism (What is alcoholism?), coma, fall (What is fall?).

4627676-8 | Completed Suicide, Overdose
on Mar 24, 2005 Male patient from , 27 years of age, was treated with Serax (View Usage). Patient had the following side effects: completed suicide, overdose. Serax dosage: Po. During the same period patient was treated with DIAZEPAM (Po) (View Diazepam Review and Diazepam Label ), COCAINE (View Cocaine Review and Cocaine Label ), HEROIN (View Heroin Review and Heroin Label ), METHADONE HCL (Po) (View Methadone Hcl Review and Methadone Hcl Label ), MORPHINE (View Morphine Review and Morphine Label ), NORDAZEPAM (Po) (View Nordazepam Review and Nordazepam Label ).

4614248-4 | Glasgow Coma Scale Abnormal, Hyponatraemia, Neuroleptic Malignant Syndrome, Renal Failure, Staphylococcal Infection
on Mar 02, 2005 Male patient from , 46 years of age, was diagnosed with alcohol withdrawal syndrome and was treated with Serax (View Usage). After Serax was administered, patient had the following side effects: glasgow coma scale abnormal, hyponatraemia, neuroleptic malignant syndrome, renal failure, staphylococcal infection (What is staphylococcal infection?). Serax dosage: Qd; Po. During the same period patient was treated with SEROPRAM (Qd; Po) (View Seropram Review and Seropram Label ), TIAPRIDAL (200 Mh; Qd; Po) (View Tiapridal Review and Tiapridal Label ). Patient was hospitalized.

4607901-X | Hepatitis C, Lymphadenopathy, Pyrexia, Rash Maculo-papular, Rash Pruritic
Patient was taking Serax (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis c (What is hepatitis c?), lymphadenopathy, pyrexia, rash maculo-papular, rash pruritic on Mar 02, 2005 from Additional patient health information: Male patient , 35 years of age, . Serax dosage: 50 Mg; Tid; Po. During the same period patient was treated with PHENOBARBITAL ({NULL}) (Po) (View Phenobarbital ({null}) Review and Phenobarbital ({null}) Label ), SUSTIVA (EFAVIRENZ) (600 Mg; Qd; Po) (View Sustiva (efavirenz) Review and Sustiva (efavirenz) Label ), OXCARBAZEPINE ({NULL}) (1200 Mg; Qd; Po) (View Oxcarbazepine ({null}) Review and Oxcarbazepine ({null}) Label ), VIDEX (400 Mg; Qd; Po) (View Videx Review and Videx Label ), ZERIT (60 Mg;qd; Po) (View Zerit Review and Zerit Label ). Patient was hospitalized.

4570088-6 | Cardiac Arrest, Hypertension
Adverse event was reported on Jan 19, 2005 by a Male patient taking Serax (View Usage) (Dosage: 50 Mg;tid;po) . Location: , 45 years of age, Patient had the following side effects: cardiac arrest (What is cardiac arrest?), hypertension. During the same period patient was treated with EFFEXOR (See Image) (View Effexor Review and Effexor Label ), STABLON ({NULL}) (X1;po) (View Stablon ({null}) Review and Stablon ({null}) Label ). Patient was hospitalized.

4563681-8 | Coma, Hemiparesis, Overdose
on Jan 17, 2005 Male patient from , 51 years of age, was treated with Serax (View Usage). After Serax was administered, patient had the following side effects: coma, hemiparesis, overdose. Serax dosage: Po. During the same period patient was treated with STABLON (View Stablon Review and Stablon Label ), LASILIX (View Lasilix Review and Lasilix Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), EUPANTOL (View Eupantol Review and Eupantol Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ). Patient was hospitalized.

4563680-6 | Hepatitis C, Lymphadenopathy, Pain, Pyrexia, Rash Maculo-papular, Rash Pruritic
on Jan 17, 2005 Male patient from , 35 years of age, was treated with Serax (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis c (What is hepatitis c?), lymphadenopathy, pain (What is pain?), pyrexia, rash maculo-papular, rash pruritic. Serax dosage: 50 Mg; Tid; Po. During the same period patient was treated with PHENOBARBITAL (Po) (View Phenobarbital Review and Phenobarbital Label ), SUSTIVA (600 Mg; Qd; Po) (View Sustiva Review and Sustiva Label ), OXCARBAZEPINE (1200 Mg; Qd; Po) (View Oxcarbazepine Review and Oxcarbazepine Label ), VIDEX (400 Mg; Qd; Po) (View Videx Review and Videx Label ), ZERIT (60 Mg; Qd; Po) (View Zerit Review and Zerit Label ). Patient was hospitalized.

4559431-1 | Hyperkalaemia
Patient was taking Serax (View Usage). Patient had the following side effects: hyperkalaemia on Jan 07, 2005 from Additional patient health information: Female patient , 61 years of age, . Serax dosage: 0.5 Mg; Qd; Po. During the same period patient was treated with BACTRIM (Po) (View Bactrim Review and Bactrim Label ), OXYBUTYNIN (Qd; Po) (View Oxybutynin Review and Oxybutynin Label ), FERO GRAD LP (Po) (View Fero-grad Lp Review and Fero-grad Lp Label ), DOMPERIDONE (Po) (View Domperidone Review and Domperidone Label ), DAONIL (View Daonil Review and Daonil Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), SEROPAM (View Seropam Review and Seropam Label ). Patient was hospitalized.